Lag period in anti tb drugs
Reading Document
Medical Text Search
lag period anti-tuberculosis drugs bactericidal activity
Medical Text Search
tuberculosis drug mechanism latent period isoniazid rifampicin pyrazinamide
GradeResponse
GradeResponse
The retrieved results don't directly address "lag period." I'll answer from my knowledge, supplemented by what was retrieved.
Lag Period in Anti-TB Drugs
Definition
The lag period (also called the lag phase) in the context of anti-TB drugs refers to the initial delay before a drug exerts its full bactericidal or bacteriostatic effect on Mycobacterium tuberculosis. During this phase, drug exposure has occurred but the measurable kill of viable bacilli has not yet begun or is minimal.
Concept in Pharmacodynamics of Anti-TB Agents
Anti-TB drug activity is described in three phases:
| Phase | Description |
|---|---|
| Lag phase | Delay before drug-induced killing begins |
| Log-kill phase | Exponential decline in viable bacilli |
| Plateau/tail phase | Residual "persisters" that resist killing |
Lag Period of Specific Drugs
| Drug | Lag Period | Notes |
|---|---|---|
| Isoniazid (INH) | Very short (~2–4 h) | Rapid early bactericidal activity (EBA); kills ~90% of bacilli in first 2 days |
| Rifampicin | Short | Excellent sterilizing activity; targets RNA polymerase — acts quickly on actively dividing bacilli |
| Pyrazinamide | Longer lag | Low EBA in first 2 days; acts mainly on semi-dormant, acidic environment persisters; full activity takes days–weeks |
| Ethambutol | Moderate | Primarily bacteriostatic; inhibits arabinogalactan synthesis — slower onset |
| Streptomycin | Short | Good EBA; aminoglycoside targeting ribosomal function |
Why Does the Lag Period Occur?
- Time required for intracellular drug accumulation — especially relevant for intracellular mycobacteria within macrophages.
- Pro-drug activation — Isoniazid requires activation by KatG (catalase-peroxidase); pyrazinamide requires activation by pyrazinamidase (PncA) to pyrazinoic acid. This enzymatic conversion introduces a lag.
- Metabolic state of bacilli — Dormant/slowly replicating bacilli (persisters) are inherently less susceptible; drugs that target them (e.g., pyrazinamide) show a longer lag because these bacteria have reduced metabolic activity.
- Target access — Some drugs must penetrate caseous granulomas, which slows onset.
Clinical Significance
-
Early Bactericidal Activity (EBA) is the standard metric used to quantify how quickly a drug reduces viable bacilli in sputum within the first 2 days of treatment. It directly reflects the lag period — a short lag = high EBA.
- INH has the highest EBA among all anti-TB drugs
- Pyrazinamide has low EBA despite being critical for sterilization
-
Infectiousness of patients decreases as bactericidal drugs (INH, rifampicin) overcome the lag period — typically within 2 weeks of starting therapy.
-
Drug-resistance implications: During the lag period, bacilli are still viable and replicating, increasing the theoretical risk of selecting for resistant mutants — a key reason combination therapy is mandatory.
-
Sterilizing activity vs. bactericidal activity: Pyrazinamide's longer lag but profound sterilizing effect on persisters is why it is essential in the intensive phase (first 2 months), allowing the continuation phase to be shortened from 9–12 months to 6 months.
Summary Table: EBA as a Surrogate for Lag Period
| Drug | EBA (log₁₀ CFU/mL/day) | Relative Lag |
|---|---|---|
| Isoniazid | ~0.4–0.8 | Shortest |
| Rifampicin | ~0.1–0.2 (days 1–2) | Short |
| Streptomycin | ~0.2 | Short |
| Ethambutol | ~0.1 | Moderate |
| Pyrazinamide | ~0.0–0.1 | Longest |
(Harrison's Principles of Internal Medicine, 21st Ed., p. 5163, 5267)
The concept of the lag period is most tested in the context of pyrazinamide (longest lag, acts on persisters in acidic pH) vs. isoniazid (shortest lag, greatest EBA). In pharmacology exams, this distinction is a classic comparison point.
This is a shared conversation. Sign in to Orris to start your own chat.